Starring TREK-1: the next generation of vascular K+ channels.
Bryan
Robert M
RM
Joseph
Biny K
BK
Lloyd
Eric
E
Rusch
Nancy J
NJ
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D002339:Carotid Arteries / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects*; D017078:Laser-Doppler Flowmetry; D051379:Mice; D018345:Mice, Knockout; D024683:Potassium Channels, Tandem Pore Domain / Q000096:biosynthesis* / Q000172:deficiency; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D017962:alpha-Linolenic Acid / Q000494:pharmacology*
D024683:Potassium Channels, Tandem Pore Domain; D014665:Vasodilator Agents; C103742:potassium channel protein TREK-1; D017962:alpha-Linolenic Acid